108 related articles for article (PubMed ID: 19610054)
21. Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection.
Cheong JY; Shin HD; Kim YJ; Cho SW
J Med Virol; 2013 May; 85(5):808-14. PubMed ID: 23508906
[TBL] [Abstract][Full Text] [Related]
22. The immune response induced by hepatitis B virus principal antigens.
Huang CF; Lin SS; Ho YC; Chen FL; Yang CC
Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus immunopathogenesis.
Chisari FV; Ferrari C
Annu Rev Immunol; 1995; 13():29-60. PubMed ID: 7612225
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59.
Qu Z; Liang X; Liu Y; Du J; Liu S; Sun W
Mol Immunol; 2009 Dec; 47(2-3):283-9. PubMed ID: 19804910
[TBL] [Abstract][Full Text] [Related]
25. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection.
Ramezani A; Hasanjani Roshan MR; Kalantar E; Eslamifar A; Banifazl M; Taeb J; Aghakhani A; Gachkar L; Velayati AA
J Gastroenterol Hepatol; 2008 Nov; 23(11):1716-21. PubMed ID: 18761557
[TBL] [Abstract][Full Text] [Related]
26. Role of HLA allele polymorphism in chronic hepatitis B virus infection and HBV vaccine sensitivity in patients from eastern Turkey.
Albayrak A; Ertek M; Tasyaran MA; Pirim I
Biochem Genet; 2011 Apr; 49(3-4):258-69. PubMed ID: 21188498
[TBL] [Abstract][Full Text] [Related]
27. Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model.
Zhang Z; Pan Q; Duan XY; Liu Q; Mo GY; Rao GR; Fan JG
J Gastroenterol Hepatol; 2012 Dec; 27(12):1858-64. PubMed ID: 22989301
[TBL] [Abstract][Full Text] [Related]
28. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
29. The influence of HLA alleles and HBV subgenotyes on the outcomes of HBV infections in Northeast China.
Li X; Liu W; Wang H; Jin X; Fang S; Shi Y; Liu Z; Zhang S; Yang S
Virus Res; 2012 Jan; 163(1):328-33. PubMed ID: 22056847
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection.
Zamani AG; Barlas IO; Durakbasi-Dursun G; Ural O; Erdal E; Yildirim MS
Int J Immunogenet; 2013 Dec; 40(6):482-7. PubMed ID: 23560484
[TBL] [Abstract][Full Text] [Related]
31. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B.
Lin CL; Liao LY; Wang CS; Chen PJ; Lai MY; Chen DS; Kao JH
Liver Int; 2005 Jun; 25(3):564-70. PubMed ID: 15910494
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus genotypes in Korea: an endemic area of hepatitis B virus infection.
Song BC; Cui XJ; Kim H
Intervirology; 2005; 48(2-3):133-7. PubMed ID: 15812186
[TBL] [Abstract][Full Text] [Related]
33. Genetic variants in ERBB4 is associated with chronic hepatitis B virus infection.
Liu Y; Zhou Q; He XS; Song LM; Chen L; Jiao WJ; Shen T; Yao S; Wu H; Hu ZB; Gao TM; Li JM
Oncotarget; 2016 Jan; 7(4):4981-92. PubMed ID: 26701850
[TBL] [Abstract][Full Text] [Related]
34. Correlation between interleukin‑23 receptor gene polymorphisms and risk of hepatitis B virus infection in patients.
Peng Q; Qin Y; Chen Z; Deng Y; Xu J; Li S; Qin X
Mol Med Rep; 2013 Aug; 8(2):613-20. PubMed ID: 23807368
[TBL] [Abstract][Full Text] [Related]
35. Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J.
Liu CJ; Kao JH
Semin Liver Dis; 2013 May; 33(2):97-102. PubMed ID: 23749665
[TBL] [Abstract][Full Text] [Related]
36. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
Migita K; Miyazoe S; Maeda Y; Daikoku M; Abiru S; Ueki T; Yano K; Nagaoka S; Matsumoto T; Nakao K; Hamasaki K; Yatsuhashi H; Ishibashi H; Eguchi K
J Hepatol; 2005 Apr; 42(4):505-10. PubMed ID: 15763337
[TBL] [Abstract][Full Text] [Related]
37. Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus.
Chen CC; Chang CM; Sun CP; Yu CP; Wu PY; Jeng KS; Hu CP; Chen PJ; Wu JC; Shih CH; Gershwin ME; Tao MH
Gene Ther; 2012 Jan; 19(1):25-33. PubMed ID: 21562593
[TBL] [Abstract][Full Text] [Related]
38. Cytokine gene polymorphisms in patients infected with hepatitis B virus.
Ben-Ari Z; Mor E; Papo O; Kfir B; Sulkes J; Tambur AR; Tur-Kaspa R; Klein T
Am J Gastroenterol; 2003 Jan; 98(1):144-50. PubMed ID: 12526950
[TBL] [Abstract][Full Text] [Related]
39. [Association of Taq I T/C and Fok I C/T polymorphisms of vitamin D receptor gene with outcome of hepatitis B virus infection].
Li JH; Li HQ; Li Z; Liu Y; Gao JR; Zeng XJ; Gou CY; Zhu XL; Guo XH; Pan L; Li H
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1952-6. PubMed ID: 17064588
[TBL] [Abstract][Full Text] [Related]
40. Association of IFNAR2 and IL10RB genes in chronic hepatitis B virus infection.
Romporn S; Hirankarn N; Tangkijvanich P; Kimkong I
Tissue Antigens; 2013 Jul; 82(1):21-5. PubMed ID: 23745570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
